Talks
ORCHESTRA Trial: Debulking in mCRC
March 18, 2026
Zongertinib Receives FDA Approval
March 2, 2026
TTF Approved in Pancreatic Cancer
February 19, 2026
Time-of-Day Immunochemotherapy: Randomized Phase 3 Trial
February 9, 2026
Tiragolumab in esophageal SCC?
December 31, 2025
Tiragolumab in esophageal SCC?
December 31, 2025
Tinengotinib in cholangiocarcinoma
December 18, 2025
Tinengotinib in cholangiocarcinoma
December 18, 2025
PAXG for periop chemo in pancreas cancer
December 18, 2025
PAXG for periop chemo in pancreas cancer
December 18, 2025
HERIZON-GEA-01 positive in HER2+ GEJ ca
December 1, 2025
HERIZON-GEA-01 positive in HER2+ GEJ ca
December 1, 2025
CLDN18.2 in pancreas ca
December 1, 2025
CLDN18.2 in pancreas ca
December 1, 2025
How would I treat resectable GEJ cancer?
December 1, 2025
How would I treat resectable GEJ cancer?
December 1, 2025
duravalumab approved for GEJ ca
November 25, 2025
duravalumab approved for GEJ ca
November 25, 2025
is FGFR2b exp in GEJ ca a target?
November 22, 2025
is FGFR2b exp in GEJ ca a target?
November 22, 2025
LEAP-012 - No further development?
November 3, 2025
LEAP-012 - No further development?
November 3, 2025
Role for IO in MSS colon cancer?
October 31, 2025
Role for IO in MSS colon cancer?
October 31, 2025
OS results from MATTERHORN trial
October 30, 2025
OS results from MATTERHORN trial
October 30, 2025
Does HIPEC/CRS help?
October 19, 2025
Does HIPEC/CRS help?
October 19, 2025
HAI pumps in BTC?
October 15, 2025
HAI pumps in BTC?
October 15, 2025
a new triplet for BRAFV600E mCRC?
August 31, 2025
a new triplet for BRAFV600E mCRC?
August 31, 2025
a potential new option in BTC?
August 31, 2025
a potential new option in BTC?
August 31, 2025
NCCN updates for early stage GE cancer?
August 27, 2025
NCCN updates for early stage GE cancer?
August 27, 2025
updated OS from Keynote 585
August 25, 2025
updated OS from Keynote 585
August 25, 2025
CLDN18.2 and Prognostic Implications
August 9, 2025
CLDN18.2 and Prognostic Implications
August 9, 2025
NUC-1031 Negative
August 1, 2025
NUC-1031 Negative
August 1, 2025
KEYNOTE-937 Negative
August 1, 2025
KEYNOTE-937 Negative
August 1, 2025
Can we target CEACAM5 in CRC?
August 1, 2025
Can we target CEACAM5 in CRC?
August 1, 2025
LEAP-015 Negative
August 1, 2025
LEAP-015 Negative
August 1, 2025
HIMALAYA 5-year Median OS Results
July 31, 2025
HIMALAYA 5-year Median OS Results
July 31, 2025
Imbrave-152 Negative
July 29, 2025
Imbrave-152 Negative
July 29, 2025
Zanidatamab + chemo in HER2+ gastric ca
July 22, 2025
Zanidatamab + chemo in HER2+ gastric ca
July 22, 2025
Adjuvant therapy in BTC?
July 12, 2025
Adjuvant therapy in BTC?
July 12, 2025
FORTITUDE 101 positive
June 30, 2025
FORTITUDE 101 positive
June 30, 2025
structured exercise in colon cancer pts
June 30, 2025
DESTINY GASTRIC -04 positive
June 26, 2025
Loading logo
Close button
Why are you reporting this TALK?